See a Demo

Category: Blog

TrialAssure cubes divider

This week in transparency news: February 16 – February 22, 2019

by Staff Writer | February 2019

Posted in Blog
Read More
Should people share their DNA for drug development purposes? – USA Today Many people don’t realize that sharing a DNA sample with Ancestry.com, 23andMe and others can result in their data being shared. However, this week, the companies pledged that they would disclose when data is shared with corporations or the government. With a $300 million investment by GSK in 23andMe, they state that approximately 80 percent of customers have agreed to share their DNA data. This data is being de-identified before it is shared.

This week in transparency news: February 9 – February 15, 2019

by Staff Writer | February 2019

Posted in Blog
Read More
The U.S. Senate had voted in favor of an opioid bill that expands Open Payments to include payments made to Nurse Practitioners, Physician Assistants, Nurse Midwifes, Nurse Anesthetists, and Clinical Nurse Specialists, in addition to current physician reporting requirements. This will go into effect beginning January 1, 2022. Inconsistent Clinical Trial Disclosure and Lack of Compliance Across Big Pharma

This week in transparency news: February 2 – February 8, 2019

by Staff Writer | February 2019

Posted in Blog
Read More

This week in transparency news: January 26 – February 1, 2019

by Staff Writer | February 2019

Posted in Blog
Read More

This week in transparency news: January 19-25, 2019

by Staff Writer | January 2019

Posted in Blog
Read More
clinicaltrials.gov ct.gov fda clinical trial registry disclosure transparency services solutions trialassure technology clinical trials

This week in transparency news: January 12-18, 2019

by Staff Writer | January 2019

Posted in Blog
Read More

This week in transparency news: January 5-11, 2019

by Staff Writer | January 2019

Posted in Blog
Read More

This week in transparency news: December 22, 2018 – January 4, 2019

by Staff Writer | January 2019

Posted in Blog
Read More
Outsourcing-Pharma released a State of the Industry report that sheds light on the global pharmaceutical industry. One of the key findings in the report showed that more than half of survey respondents believe that industry initiatives will lead to greater transparency. The report points to a new pilot program launched earlier this year by the FDA to increase transparency. Clinical Trial Transparency Software client feedback

This week in transparency news: December 15-21, 2018

by Staff Writer | December 2018

Posted in Blog
Read More

FORBES: How Blockchain Will Revolutionize The Pharmaceutical Industry

by Staff Writer | December 2018

Posted in Blog
Read More
Get in Touch

Looking to streamline your clinical trial disclosure and transparency efforts?

TrialAssure is ready to help your organization embark on a Transparency Transformation!

To learn more about the TrialAssure Transparency Suite, specific products, or our company, contact us below.

Yes, please send me more information about TrialAssure.